Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v2-FR | Version v1-EN | |
---|---|---|
Language | French | English |
Date Updated | 2017-03-13 | 2017-03-13 |
Drug Identification Number | 00695033 | 00695033 |
Brand name | SELAX SYR 20MG/5ML USP | SELAX SYR 20MG/5ML USP |
Common or Proper name | Docusate Sodium Syrup, USP | Docusate Sodium Syrup, USP |
Company Name | ODAN LABORATORIES LTD | ODAN LABORATORIES LTD |
Ingredients | DOCUSATE SODIUM | DOCUSATE SODIUM |
Strength(s) | 20MG | 20MG |
Dosage form(s) | SYRUP | SYRUP |
Route of administration | ORAL | ORAL |
Packaging size | 250 mL | 250 mL |
ATC code | A06AA | A06AA |
ATC description | DRUGS FOR CONSTIPATION | DRUGS FOR CONSTIPATION |
Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
Anticipated start date | ||
Actual start date | 2016-04-15 | 2016-04-15 |
Estimated end date | Unknown | Unknown |
Actual end date | ||
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | ||
Health Canada comments |